S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results (2013/3/27)|
|Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering (2013/5/16)|
|Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock (2013/5/15)|
|Cyclacel Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference (2013/4/23)|
|Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial Results (2013/5/10)|
|Cyclacel Reports First Quarter 2013 Financial Results (2013/5/13)|
|Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene and Dismissal of All Claims in Their Patent Litigation (2013/4/4)|
|Combination Potential of Cyclacel's Sapacitabine and Seliciclib Reported at AACR (2013/4/9)|
|AACR Press Conference Highlights Combination Potential of Two Cyclacel Drugs (2013/4/8)|
|Cyclacel Reports Updated Phase 2 Survival Data of Sapacitabine for MDS (2013/4/30)|
Click above to view more mutual fund data and stats for cycc - Cyclacel Pharmaceuticals, Inc..